Polyphyllin VII is a biologically active herbal monomer extracted from the traditional Chinese herbal medicine Chonglou. Many studies have demonstrated the anticancer activity of polyphyllin VII against various types of cancers, such as colon, liver, and lung cancer, but its effect on breast cancer has not been elucidated. In this study, we demonstrate that polyphyllin VII inhibited proliferation, increased production of intracellular reactive oxygen species, and decreased mitochondrial membrane potential in breast cancer cells. Notably, polyphyllin VII also induced apoptosis via the mitochondrial pathway. Transcriptome sequencing was used to analyze the targets of PPVII in regulating breast cancer cells. Mechanistic studies showed that polyphyllin VII downregulated Son of Sevenless1 (SOS1) and inhibited the MAPK/ERK pathway. Furthermore, PPVII exerted strong antitumor effects in nude mice injected with breast cancer cells. Our results suggest that PPVII may promote apoptosis through regulating the SOS1/MAPK/ERK pathway, making it a possible candidate target for the treatment of breast cancer.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1142/S0192415X24500368 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Polyphyllin VII enhances the sensitivity of endometrial carcinoma cells to medroxyprogesterone acetate through upregulating miR‑33a‑5p expression.
Oncol Lett
February 2025
Department of Traditional Chinese Medicine, Wujin Hospital Affiliated with Jiangsu University, Changzhou, Jiangsu 213017, P.R. China.
Article Synopsis
- Endometrial carcinoma (EC) often resists hormone therapies like medroxyprogesterone acetate (MPA), necessitating new treatment approaches.
- This study examines how polyphyllin VII (PPVII) can improve MPA effectiveness by regulating microRNA (miR)-33a-5p in an MPA-resistant Ishikawa cell line.
- Results showed that combining PPVII with MPA significantly reduced cell viability and increased apoptosis, while PPVII enhanced miR-33a-5p levels, suggesting a potential therapeutic strategy for overcoming hormone resistance in EC.
Polyphyllin VII ameliorates neuroinflammation and brain injury via modulating Treg/Th17 balance in a mouse model of cerebral ischemia-reperfusion injury.
Int Immunopharmacol
December 2024
Department of Neurology, China-Japan Union Hospital of Jilin University, Changchun 130000, China. Electronic address:
Article Synopsis
- Dysregulation of Th17 and Treg cells is linked to brain damage during cerebral ischemia, suggesting that balancing these cell types could aid in post-stroke treatment.
- Polyphyllin VII (PVII), a compound from the Rhizoma Paridis herb, shows promise in reducing brain damage and improving recovery in a mouse model of stroke by promoting Treg cells and reducing Th1/Th17 cells.
- PVII operates by inhibiting mTORC1, affecting T cell metabolism and polarization, ultimately leading to a protective effect against cerebral ischemia-reperfusion injury.
The role of saponins on anti-cancer: The potential mechanism and molecular targets.
Heliyon
September 2024
School of Pharmacy, Southwest Medical University, Luzhou, 646000, China.
Article Synopsis
- Cancer is caused by uncontrolled cell growth, leading to spreading in the body, and traditional Chinese medicine has introduced new treatment methods.
- A Chinese herbal medicine referred to as RPS has documented anti-cancer effects, showing its potential to combat cancer through various mechanisms such as inhibiting tumor growth and promoting cell death.
- The review highlights key compounds like polyphyllins that exhibit strong anti-cancer properties, aiming to provide insights for future research and applications in cancer therapies.
Study on Synthesis and Regulation of PPVI and PPVII in with UV.
Metabolites
August 2024
Tea Research Institute, Chinese Academy of Agricultural Sciences, Hangzhou 311300, China.
Article Synopsis
- Smith var. (Franch.) Hara is a medicinal plant with beneficial components called parissaponins, known for their anti-inflammatory and anti-tumor effects, prompting research on enhancing these compounds through UV treatments.
- * In a study, UV treatments (UVA, UVB, UVC) resulted in a significant increase in PolyPhyllin VII (PPVII) content by 32.43% with UVC after 4 hours, while other treatments decreased relevant saponin levels.
- * The study found that UV exposure activated several enzymes involved in saponin synthesis and affected various physiological parameters, providing insights into using UV light for improving medicinal properties in plants, which is valuable for future production techniques.*
Polyphyllin VII as a potential medication for targeting epithelial mesenchymal transitionin in thyroid cancer.
J Pharmacol Sci
October 2024
Biomedical Research Institute, Hubei University of Medicine, Shiyan City, Hubei Province, PR China; Renmin Hospital, Hubei University of Medicine, Shiyan City, Hubei Province, PR China; Hubei Key Laboratory of Wudang Local Chinese Medicine Research, Shiyan City, Hubei Province, PR China. Electronic address:
The need for novel anti-thyroid cancer (TC) medications is urgent due to the rising incidence and metastatic rates of malignant TC. In this study, we investigated the effect of Polyphyllin VII (PPVII) to TC cells, and explored their potential mechanism. B-CPAP and TPC-1 cells, were used to analyze the antitumor activity of PPVII by quantifying cell growth and metastasis as well as to study the effect on epithelial mesenchymal transition (EMT).
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!